One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Baird boosted their target price on shares of Neurocrine Biosciences from $117.00 to $125.00 in a research report on Friday, August 5th. They set an "equal weight" rating and a $110.00 target price on the stock. Wells Fargo & Company began coverage on shares of Neurocrine Biosciences in a research report on Monday, September 26th. Mizuho boosted their target price on shares of Neurocrine Biosciences from $95.00 to $98.00 and gave the stock a "neutral" rating in a research report on Monday, August 8th. Morgan Stanley boosted their target price on shares of Neurocrine Biosciences from $100.00 to $102.00 and gave the stock an "equal weight" rating in a research report on Friday, July 15th. Barclays lifted their price objective on shares of Neurocrine Biosciences from $110.00 to $113.00 and gave the stock an "overweight" rating in a research report on Friday, August 5th. NBIX has been the topic of a number of other research reports. Neurocrine Biosciences ( NASDAQ:NBIX - Get Rating) was upgraded by equities research analysts at from a "buy" rating to a "strong-buy" rating in a research note issued to investors on Friday. 7 Blue-Chip Dividend Stocks That Won’t be Impacted by Rising Interest Rates.7 Mid-Cap Stocks That Can be the Perfect Fit at Any Time.7 Stocks to Buy to Outrun Rising Interest Rates.7 Sports Betting Stocks to Buy for Their Long-Term Possibilities.7 Water Stocks to Buy as the World Dries Up.7 Solar Stocks Leading the Clean Energy Boom.7 Railroad Stocks to Keep Your Portfolio Chugging Along.7 Agricultural Stocks to Buy to Keep Your Portfolio Well Fed.7 Streaming Stocks that Will Stand up to Streaming Fatigue.7 Cash Rich Stocks That Offer Safety in Any Market.7 Small-Cap Stocks That Could Rocket Higher in 2023.Kinder Morgan Results Benefit From Geopolitical Tailwinds.AT&T Jumps Higher Thursday After Better-Than-Expected Q3 Results.Tesla Stock Slides After Revenue Miss, Musk Maintains Optimism.Will Matador Share Price Get A Boost From Improved Credit Rating?.Freeport McMoran Shares Rally Despite Weakening Copper Prices.American Express Beats Earnings & Revenue Views, Raises Guidance.Snap Stock Falls As User Growth Slows To Single-Digits.Should Investors Raise a Glass to Boston Beer Company?. The Trader's Guide to Equities Research.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |